The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
130 jobs Number of planned job creations
Announcement Date
24 November 2014
Employment effect (start)
1 March 2015
Foreseen end date
Description
Sandoz, the generic pharmaceutical division of Novartis, has announced its plan to create 130 new jobs in Stryków. The company uses automated production lines and hence is looking for workers with computer skills. The company has invested PLN 125 million (EUR 30.12 million) since 2013 in Poland and the new production lines will be operational at the beginning of March 2015.
Sandoz has been operating in Poland since 2010 and at its two locations (Warszawa and Stryków) employs currently 1,200 people.
Sources
24 November 2014: Gazeta Wyborcza
Citation
Eurofound (2014), Sandoz, Business expansion in Poland, factsheet number 78660, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/78660.